Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Opadeyi , A"'
Publikováno v:
Ibom Medical Journal, Vol 17, Iss 2 (2024)
Background: Drug-drug interactions software is used as a tool to investigate clinically harmful interactions. Prescribers need to be aware of these tools to improve the quality of drug prescriptions, thus ensuring better patient care. Drug-drug inter
Externí odkaz:
https://doaj.org/article/e2b9e77f6ed94917a11897a6574882ba
Autor:
Oseremen Godstime Oriaifo, Abimbola Olubukunola Opadeyi, Tracy Oseremen Oriaifo, Ambrose Ohumagho Isah
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 4, Pp n/a-n/a (2024)
Abstract Drug–drug interactions are preventable causes of adverse events. Different factors have been recognized as important predictors of drug–drug interactions but few studies have addressed these predictors in patients admitted into medical w
Externí odkaz:
https://doaj.org/article/be2e00fd082944dfb3666b2a3839af21
Autor:
Oriaifo, Oseremen Godstime1 (AUTHOR) oseremenoriaifo@gmail.com, Opadeyi, Abimbola Olubukunola2,3 (AUTHOR), Oriaifo, Tracy Oseremen4 (AUTHOR), Isah, Ambrose Ohumagho2,3 (AUTHOR)
Publikováno v:
CTS: Clinical & Translational Science. Apr2024, Vol. 17 Issue 4, p1-5. 5p.
Autor:
Ogar, Comfort K., Gilbert, Hannah N., Bloem, Lourens T., Leopold, Christine, Bassi, Peter U., Katagum, Yahaya M., Osakwe, Adeline I., Opadeyi, Abimbola O., Oreagba, Ibrahim, Mbo, Danjuma N.D., Mantel-Teeuwisse, Aukje K., De Bruin, Marie L.
Publikováno v:
In Vaccine 3 October 2024 42(23)
Autor:
Ambrose O. Isah, Abimbola O. Opadeyi, Henry Tumwijukye, Frank Cobelens, Diede Smith, Margareth Ndomondo-Sigonda, Linda Harmark, Paul Tanui, Edine Tiemersma, Blandina T. Mmbaga, Gugu Mahlangu, Stephen A. Ayinbuomwan, Rachida Soulaymani, Jayesh M. Pandit
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 14 (2023)
Background: An important factor hindering the growth of pharmacovigilance (PV) in resource-limited settings is the lack of adequate funds to establish a functional National Pharmacovigilance System. Consequently, the crucial function of monitoring an
Externí odkaz:
https://doaj.org/article/bd7d261bc4d44a37aebb4ab90e4e04a1
Publikováno v:
Babcock University Medical Journal, Vol 5, Iss 2 (2022)
Objective: The antimalarial preferences, tolerability, and cost of the Artemisinin-based combination therapies (ACTs) among adult patients and caregivers are largely understudied despite being the recommended treatment for Plasmodium falciparum. We,
Externí odkaz:
https://doaj.org/article/917c5498b7164ef6ac0de166720335cd
Publikováno v:
Kanem Journal of Medical Sciences, Vol 15, Iss 1, Pp 54-64 (2021)
Background: In Nigeria, reporting pharmacovigilance issues including adverse drug reactions (ADRs) from health facilities is encouraged especially by health care professionals (HCPs). Objectives: This study assessed the knowledge, attitude and practi
Externí odkaz:
https://doaj.org/article/7932b28db48b4b79a76ddbe42a48c6b9
Publikováno v:
Annals of Health Research, Vol 6, Iss 1, Pp 108-113 (2020)
Background: An important aspect of the surgical management of breast cancer is loco-regional control which can be accomplished by either breast conservation surgery or mastectomy. Objective: To examine the outcome of the operation of mastectomy wi
Externí odkaz:
https://doaj.org/article/8e78ae7074f84870be04333b8db7990d
Publikováno v:
BMC Pharmacology and Toxicology, Vol 19, Iss 1, Pp 1-8 (2018)
Abstract Background WHO pharmacovigilance indicators have been recommended as a useful tool towards improving pharmacovigilance activities. Nigeria with a myriad of medicines related issues is encouraging the growth of pharmacovigilance at peripheral
Externí odkaz:
https://doaj.org/article/4d90233816de4b0382e0d45af0948d4a
Autor:
Isezuo , S, Asinobi , A, Opadeyi , A, Ademola , A, Ogah , O, Ogbera , A, Familoni , O, Ulasi , I, Sani , M, Ogun , S, Kadiri , S, Salako , B, Mbakwem , A, Isah , A, Aderibigbe , A, Onwubere , B, Omotoso , ABO, Arije , A, Arogundade , F
Publikováno v:
Nigerian Medical Practitioner; Vol. 83 No. 1-3 (2023); 3-21
Hypertension, defined as blood pressure > 140/90 mmHg, has assumed greater public health importance in Nigeria in the last 2 decades. Many reports put the adult prevalence rates at 20-40%, with some major ones specifically reporting 27.8% and 28.9%.